AUM
Not publicly reported
Estimated Dry Powder
Not publicly reported
Fund Size (Latest)
Not publicly reported
Estimated Cheque Size
Not publicly reported
Stages
- Series A
- Unspecified Round
- Early Stage
Fund Details
Year Established
2022
HQ
1230 Avenue of the Americas,16th Floor, New York, NY, 10020, US, North America
HQ Phone
+1 212 328 3790
About
Pathway to Cures is a New York-based venture capital firm that invests in early-stage companies developing cures, therapies, or enabling technologies in support of the inheritable blood and bleeding disorders community across the US. Pathway to Cures is a captive arm of National Bleeding Disorders Foundation.
HQ Map
No mappable locations available.
Locations
Tel: +1 212 328 3790View map